Jeet Mukherjee
Stock Analyst at BTIG
(3.73)
# 765
Out of 5,043 analysts
10
Total ratings
70%
Success rate
6.53%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jeet Mukherjee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NRIX Nurix Therapeutics | Maintains: Buy | $35 → $27 | $12.02 | +124.63% | 2 | Oct 23, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $59 → $75 | $60.92 | +23.11% | 2 | Oct 22, 2025 | |
| CATX Perspective Therapeutics | Reiterates: Buy | $14 | $3.08 | +354.55% | 2 | Oct 13, 2025 | |
| MNPR Monopar Therapeutics | Maintains: Buy | $87 → $104 | $80.12 | +29.81% | 3 | Sep 25, 2025 | |
| ARVN Arvinas | Maintains: Buy | $16 → $10 | $9.64 | +3.79% | 1 | Sep 18, 2025 |
Nurix Therapeutics
Oct 23, 2025
Maintains: Buy
Price Target: $35 → $27
Current: $12.02
Upside: +124.63%
Kymera Therapeutics
Oct 22, 2025
Maintains: Buy
Price Target: $59 → $75
Current: $60.92
Upside: +23.11%
Perspective Therapeutics
Oct 13, 2025
Reiterates: Buy
Price Target: $14
Current: $3.08
Upside: +354.55%
Monopar Therapeutics
Sep 25, 2025
Maintains: Buy
Price Target: $87 → $104
Current: $80.12
Upside: +29.81%
Arvinas
Sep 18, 2025
Maintains: Buy
Price Target: $16 → $10
Current: $9.64
Upside: +3.79%